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Abstract 
Seventy-two canine serum samples were analyzed for post-vaccination serum titers of rabies antibodies. The sam-
ples were divided into two groups: Group 1 dogs (n = 36) were imported dogs from the Russian Federation (n = 31) 
or Romania (n = 5), with a mean serum antibody titer value of 1.54 IU/mL. Group 2 dogs (n = 36) were Finnish dogs 
vaccinated in Finland, with a mean titer of 4.19 IU/mL. Altogether, 14 (39%) dogs (CI 95% 23–56) were without detect-
able antibodies (≤ 0.1 IU/mL) in Group 1, whereas in Group 2, all dogs had an antibody titer greater than 0.1 IU/mL. A 
statistically significant difference was observed between these groups when comparing the proportions of dogs with 
antibody levels less than or exceeding 0.5 IU/mL. In Group 1, 19 out of the 36 dogs (CI 95% 36–70) had serum titer 
values < 0.5 IU/mL, while in Group 2, only 2 dogs had serum titer values < 0.5 IU/mL. Despite the small sample size, this 
raises concern over the imported dogs having insufficient antibody levels required for international travel and implies 
that these dogs had perhaps not been vaccinated, even though they had documentation of vaccination upon arrival.
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Findings
Over 60 000 people die each year from rabies, and up to 
99% of human cases originate from a dog bite. Rabies is 
preventable by pre- and/or post-exposure prophylaxis 
consisting of a series of rabies vaccinations and in some 
cases by the use of immunoglobulins. Each year, an esti-
mated 7 million people are bitten by suspected rabid 
dogs. The most cost-effective way to eliminate human 
rabies is to eliminate rabies in dogs [1].
Rabies is endemic in the Russian Federation. In 2017, 
there were 1 791 reported cases in animals and three 
human cases [2]. In Romania, rabies cases in wild foxes 
(Vulpes vulpes) have decreased in recent years due to 
an oral vaccination program as a part of an eradication 
program partially supported by the EU. There were two 
reported cases in 2017 in domestic animals [2]. Finland 
has been officially rabies free since 1991, even though 
lyssaviruses have been detected in bats [3–5]. Canine dis-
temper (CD) is very rare in the Finnish dog population 
due to a recommended vaccination program, and during 
recent years, only imported cases have been detected [6]. 
In recent years, the import of street dogs to Finland has 
dramatically increased. In 2017, 2454 street dogs were 
imported to Finland compared to only 289 in 2010. Thus, 
in less than a decade the number of adopted street dogs 
in Finland has multiplied by a factor of ten. Import of 
street dogs represent a threat for the spread and intro-
duction of various pathogens such as rabies virus and 
canine distemper virus (CDV).
Virus-neutralizing antibody assays are used to verify 
that a humoral immune response has occurred after 
vaccination against rabies. An internationally accepted 
threshold titer of 0.5 IU/mL has been adopted [7]. Failure 
of vaccination may leave the animal susceptible to rabies 
virus and thus increase the risk developing rabies with 
an obvious zoonotic risk. Previous studies have demon-
strated that the antibody response is influenced by the 
vaccine product used, the number of vaccine doses, the 
time between vaccinations and blood sampling, and the 
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age, size, and breed of the dog [8–11]. Studies have sug-
gested a failure of vaccination in imported dogs [12, 13]. 
Rota Nodari et al. [13] found a higher vaccination failure 
rate in imported dogs (13.15%) than in those vaccinated 
in Italy (5.89%) and De Benedictis et  al. [14] reported a 
vaccination failure rate as high as a 37% in dogs crossing 
the Italian border from Eastern European countries.
The aim of this study was to investigate the rabies anti-
body levels in street dogs vaccinated in and imported 
from the Russian Federation or Romania, and to compare 
the antibody titers with those of dogs vaccinated in Fin-
land. The need to compare these two groups arose due to 
suspicion of forged importation documents. The serum 
samples were additionally analyzed for antibodies against 
CDV since one dog in Group 1 was euthanized due to 
CD.
The study material comprised serum samples from 72 
dogs vaccinated against rabies. These were grouped in 
two groups: Street dogs imported into Finland and vac-
cinated in either the Russian Federation (n = 31), or 
Romania (n = 5) (n = 36, Group 1) and dogs born, raised 
and vaccinated in Finland (n = 36, Group 2). The samples 
were taken between January and March 2018. The short-
est time from vaccination to sampling was 3 weeks. The 
age range of the dogs was from 3 months to 16 years. Of 
all the dogs (n = 72), 54 had only been vaccinated once, 
while 18 dogs had been vaccinated at least twice. The 
antibody responses of the dogs were determined using 
the fluorescent antibody virus neutralization (FAVN) test 
[15]. CDV antibodies were determined from serum using 
a seroneutralization test [16]. Samples with a titer of < 1:8 
were considered negative. Since the serum samples were 
submitted to determine the rabies virus antibody level, 
we had no data on the CDV vaccination status in either 
group. In Finland, rabies vaccination is recommended for 
dogs at the age of 4 months and CD vaccination at the 
age of 3 months with a booster at the age of 4 months.
The Chi squared test was used to analyze the possi-
ble difference between proportions of rabies antibod-
ies (< 0.5  IU/mL; ≥ 0.5  IU/mL) and CDV antibodies 
(< 1:8; ≥ 1:8).
In Group 1, the mean titer value was 1.5 IU/mL. Mean 
titer for dogs from the Russian Federation was 1.62  IU/
mL and for Romanian dogs 1.08  IU/mL. Despite the 
group mean being over the threshold of ≥ 0.5 IU/mL, over 
half of the dogs (19/36) had an antibody level < 0.5  IU/
mL, the mode of the titer value being under the detection 
limit and the median 0.35 IU/mL. In Group 2, the mean 
titer value was 4.21  IU/mL. Two dogs (5%) had serum 
titer values under < 0.5  IU/mL (CI 95% 0–19). All dogs 
in this group had some immune response, ranging from 
0.1 IU/mL up to 10.3 IU/mL. Thirty-four dogs (94%) (CI 
95% 81–99) in Group 2 had antibody levels ≥ 0.5 IU/mL 
(Fig. 1). The findings indicate that a booster vaccination 
enhanced the immunity in both groups of dogs. Of all 
the dogs, 54 dogs that had been vaccinated once had a 
mean titer value of 2.63  IU/mL, while 18 dogs that had 
been vaccinated at least twice had a mean titer value of 
3.63  IU/mL. All the dogs that had received at least one 
booster vaccination had titer values over 0.5 IU/mL.
Within Group 1, there were 11 (31%) dogs with CDV 
antibody titer < 1:8 (CI 95% 16–48). In the Group 2, 5 
(14%) dogs had a titer value < 1:8 (CI 95% 5–30). The dif-
ference between groups was not statistically significant 
(χ2 = 2.89, df = 1, P = 0.089).
According to the legal documents accompanying 
the imported street dogs (Group 1), all had been vac-
cinated against rabies at least 21  days before arrival in 
Finland. However, 19/36 of the Group 1 dogs did not 
have the internationally accepted serum rabies antibody 
titer ≥ 0.5  IU/mL. There was a statistically significant 
difference between Groups 1 and 2 in the proportions 
of dogs with antibody levels < 0.5  IU/ml and ≥ 0.5  IU/
mL. Dogs vaccinated in Finland had a greater probabil-
ity of having antibody levels ≥ 0.5  IU/mL in comparison 
to dogs vaccinated in either the Russian Federation or 
Romania.
Despite taking into consideration factors that may 
influence antibody development following rabies vacci-
nation such as the time lapse between vaccination and 
testing, the breed, the size, the age, the type of vaccine 
and the route of administration [8–11], approximately 
90% of vaccinated dogs achieve an adequate immune 
response after one dosage of rabies vaccine and only 
Fig. 1 Rabies vaccination titers in dogs vaccinated either in the 
Russian Federation or Romania (Group 1) or in Finland (Group 2). 
Median value for Group 1 is 0.35 IU/mL with a value range of 4.5 
(0.0–4.5). Median value for Group 2 is 4.5 IU/mL with a value range of 
10.20 (0.1–10.30)
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around 1% are so-called “non-responders”, which fail 
to produce antibodies [17]. Although there are sev-
eral reasons why vaccination does not always lead to 
sufficient development of antibodies, our finding that 
39% of the imported dogs had serum titers < 0.1 IU/
mL suggests that at least some of them might not have 
been vaccinated at all. The rabies vaccines used for the 
dogs in this study should have provided a satisfactory 
response in the majority of the dogs if used and stored 
correctly. A young age of the imported dogs is not the 
reason for the low titers since only two of the imported 
dogs were under the age of 4 months at the time of vac-
cination and both had antibody titer > 0.5 IU/mL. Rota 
Nodari et  al. [13] demonstrated that the discrepancy 
in vaccine failure rates for dogs sampled > 75 days after 
vaccination was still significant between dogs vacci-
nated in Italy and imported dogs, meaning that even 
when testing > 75  days after vaccination, the vaccina-
tion response was truly different between groups.
When people have been bitten by recently imported 
street dogs, post-exposure prophylaxis is needed, 
causing considerable costs to the healthcare system 
and concern for persons who have been bitten. The 
increased adoption of street dogs from countries where 
rabies is still prevalent is an alarming trend. The data 
indicate that the level of compliance with the importa-
tion regulation may be low. Even though rabies virus 
in the Russian Federation is not circulating in the dog 
population but in wildlife, it should be considered 
whether testing for rabies vaccination antibodies should 
be required when importing dogs from rabies endemic 
countries. Norway has declared that street dogs will 
no longer be legal to commercially import. This means 
that it is no longer possible to adopt or import a street 
dog into Norway as of 1.7.2018. A private person must 
document that the dog has been owned and lived with 
the importer for a minimum of 6 months before enter-
ing Norway [18].
The data also revealed that some dogs in both groups 
had an insufficient CDV vaccination response. There was 
no statistically significant difference between Groups 
1 and 2. Since no data were available on the vaccina-
tion history of the dogs or previous exposure to CDV, 
we hypothesize that there were CDV susceptible ani-
mals among the imported street dogs as well as among 
Finnish dogs. Owners should be encouraged to maintain 
good vaccination coverage in order to prevent future 
epidemics of CVD. People importing street dogs should 
acknowledge that the importation of street dogs from 
rabies-endemic countries into the EU may pose a threat 
to human health. Even though one rabid dog might not 
cause an outbreak, the severity of rabies enforces the 
need of prophylaxis.
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